help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on February 11, 2005, doi:10.1164/rccm.200406-740OC

Am. J. Respir. Crit. Care Med., Volume 171, Number 9, May 2005, 1026-1031

A more recent version of this article appeared on May 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200406-740OCv1
171/9/1026    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sermet-Gaudelus, I.
Right arrow Articles by Edelman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sermet-Gaudelus, I.
Right arrow Articles by Edelman, A.

Submitted on June 21, 2004
Accepted on January 28, 2005

Chloride Transport in Nasal Ciliated Cells of Cystic Fibrosis Heterozygotes

Isabelle Sermet-Gaudelus1, Michele Dechaux2, Benoit Vallee3, Anne Fajac4, Emanuelle Girodon5, Thao Nguyen-Khoa6, Remi Marianovski7, Ilse Hurbain4, Jean Louis Bresson8, Gerard Lenoir9, and Aleksander Edelman3*

1 Service de Pediatrie Generale, Hopital Necker-Enfants Malades, Paris, France; Faculte de Medecine Necker, INSERM U 467, Paris, France, 2 Faculte de Medecine Necker, INSERM U 467, Paris, France; MaladesLaboratoire d'Explorations Fonctionnelles Renales, Hopital Necker-Enfants Malades, Paris, France, 3 Faculte de Medecine Necker, INSERM U 467, Paris, France, 4 Service d'Histologie-Biologie Tumorale, Hopital Tenon, Paris, France, 5 Service de Biochimie-Genetique, Hopital Henri Mondor, Creteil, France, 6 Service de Biochimie, Hopital Necker-Enfants Malades, Paris, France, 7 Service d'ORL, Hopital Necker-Enfants Malades, Paris, France, 8 Centre d'Investigation Clinique, Hopital Necker-Enfants Malades, Paris, France, 9 Service de Pediatrie Generale, Hopital Necker-Enfants Malades, Paris, France

* To whom correspondence should be addressed. E-mail: edelman{at}necker.fr.

Studying subjects heterozygous for mutations of the cystic fibrosis (CF) gene may help clarify the impact on disease onset of the CF transmembrane conductance regulator protein (CFTR) dependent chloride secretion. CFTR-mediated chloride transport was evaluated in 52 heterozygotes, 32 healthy controls and 77 CF patients with class I or II mutations. We measured the change in nasal potential difference in response to chloride-free isoproterenol solution for each subject and used a videoimaging fluorescent dye assay to assess the percentage of nasal ciliated cells with cAMP-dependent anion conductance. Our findings did not confirm the standard assumption that heterozygosity implies 50% of normal CFTR function. Half the heterozygotes had CFTR-mediated chloride transport levels below 50% of the normal range, and one third had levels similar to those of the CF patients. This reduced CFTR function was not associated with an elevated prevalence of CF-like symptoms in heterozygotes but was highly related to respiratory status in the CF patients. These data suggest that CFTR-dependent chloride conductance does not directly modulate disease severity but may be part of a more global defect in CF patients involving other CTFR functions or currently unknown modulatory factors.


Key words: Cystic fibrosis, heterozygotes, nasal potential difference, CFTR,




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Xu, P. Song, M. L. Miller, F. Borgese, S. Barone, B. Riederer, Z. Wang, S. L. Alper, J. G. Forte, G. E. Shull, et al.
Deletion of the chloride transporter Slc26a9 causes loss of tubulovesicles in parietal cells and impairs acid secretion in the stomach
PNAS, November 18, 2008; 105(46): 17955 - 17960.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
S. M. Rowe, F. Accurso, and J. P. Clancy
Detection of Cystic Fibrosis Transmembrane Conductance Regulator Activity in Early-Phase Clinical Trials
Proceedings of the ATS, August 1, 2007; 4(4): 387 - 398.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. J. Accurso
Update in cystic fibrosis 2005.
Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 944 - 947.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society
  SOTA, FL